Primary care diagnostic technology update: point-of-care testing for glycosylated haemoglobin.
Plüddemann A., Price CP., Thompson M., Wolstenholme J., Heneghan C.
CLINICAL QUESTION: In the monitoring of patients with type 1 and type 2 diabetes, what advantages does point-of-care HbA(1c) testing provide over current practice?